Stifel on Globus Medical (GMED) Warning Letter: 'Seemingly Much Ado About Nothing'
Tweet Send to a Friend
Stifel analyst Mathew Blackman reiterated a Buy rating and $80.00 price target on Globus Medical (NYSE: GMED)The analyst comments "This ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
